XML 75 R54.htm IDEA: XBRL DOCUMENT v3.21.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
 11 Months Ended 12 Months Ended
Dec. 31, 2020
Dec. 31, 2020
Dec. 31, 2019
Cash flows from operating activities:      
Net Loss $ (132,204,768)    
Changes in assets and liabilities:      
Net cash used in operating activities (1,166,549)    
Cash flows from investing activities:      
Net cash used in investing activities (413,978,000)    
Cash flows from financing activities:      
Stock issuance costs for Series D convertible preferred stock (721,852)    
Net cash provided by financing activities 415,303,148    
Cash - Beginning of period 0    
Cash - End of period 158,599 $ 158,599  
BFLY Operations Inc      
Cash flows from operating activities:      
Net Loss   (162,745,000) $ (99,697,000)
Adjustments to reconcile net loss to net cash used in operating activities:      
Depreciation and amortization   1,316,000 758,000
Provision for bad debt   576,000  
Write-down of other assets - related party   1,390,000  
Write-down of vendor advance   10,560,000 9,500,000
Non-cash interest expense on convertible debt   1,047,000  
Write-down of inventories   7,123,000 2,711,000
Stock-based compensation expense   11,004,000 6,038,000
Changes in assets and liabilities:      
Accounts receivable   (4,377,000) (1,195,000)
Inventories   (23,487,000) (1,390,000)
Prepaid expenses and other current assets   (1,082,000) (31,000)
Vendor advances   1,658,000 (48,488,000)
Due from related parties   791,000 877,000
Other assets - related party   271,000 85,000
Accounts payable   11,175,000 2,549,000
Deferred revenue   7,446,000 3,497,000
Due to related parties   148,000 (871,000)
Accrued purchase commitments   42,550,000  
Accrued expenses and other liabilities   12,936,000 5,225,000
Net cash used in operating activities   (81,700,000) (120,432,000)
Cash flows from investing activities:      
Purchases of property and equipment   (2,376,000) (4,468,000)
Net cash used in investing activities   (2,376,000) (4,468,000)
Cash flows from financing activities:      
Proceeds from exercise of stock options   2,038,000 324,000
Proceeds from loan payable   4,366,000  
Proceeds from issuance of convertible debt   50,000,000  
Payments of deferred offering costs   (657,000)  
Payments of debt issuance costs   (1,467,000)  
Net cash provided by financing activities   54,280,000 324,000
Net (decrease) increase in cash and cash equivalents   (29,796,000) (124,576,000)
Cash - Beginning of period   90,002,000 214,578,000
Cash - End of period $ 60,206,000 60,206,000 90,002,000
Supplemental disclosure of non-cash investing and financing activities      
Purchase of property and equipment   564,000 $ 75,000
Deferred offering costs and debt issuance costs   $ 3,106,000